Companion Animal Healthcare Market

• In January 2022, Zoetis received the European Commission's (EC) marketing authorization for Apoquel chewable tablets (oclacitinib) for dogs for the treatment of clinical manifestations of pruritus associated with allergic dermatitis in dogs and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
• In January 2022, Elanco received the US Food and Drug Administration (FDA) approval for Zorbium. ZORBIUM is a brand-new long-acting drug used to treat postoperative pain brought on by surgical operations in cats. One transdermal dose of ZORBIUM can offer pain relief for up to four days.

In this report, the Companion Animal Healthcare Market has been segmented by Animal Type, Product, Diagnostic Tests, End Users and Geography.

Companion Animal Healthcare Market, Segmentation by Animal Type

The Companion Animal Healthcare Market has been segmented by Animal Type into Dogs, Cats, Equine, and Others

Dogs
Dogs represent the largest segment in the Companion Animal Healthcare Market, accounting for approximately 45-50% of the market share. Their widespread ownership and increased spending on healthcare products and services drive this significant market portion.

Cats
Cats contribute around 30-35% of the market. Growing urbanization and rising pet adoption trends have increased demand for cat-specific healthcare products, including nutrition, diagnostics, and treatment.

Equine
The equine segment holds roughly 10-12% of the market. This niche segment benefits from specialized veterinary care driven by the equestrian industry and horse breeding activities, especially in North America and Europe.

Other
The “Other” category, including exotic pets and small mammals, covers about 8-10% of the market. Rising awareness and ownership of diverse companion animals have gradually expanded this segment’s healthcare requirements.

Companion Animal Healthcare Market, Segmentation by Product

The Companion Animal Healthcare Market has been segmented by Product into Feed Additives, Pharmaceuticals and Vaccines.

Feed Additives
Feed additives represent around 35-40% of the Companion Animal Healthcare Market. These products improve pet health by enhancing digestion, boosting immunity, and supporting growth, making them essential for overall animal wellness and nutrition.

Pharmaceuticals
Pharmaceuticals account for approximately 40-45% of the market. This segment includes drugs that treat various infections, chronic illnesses, and other health conditions in companion animals, driven by advances in veterinary medicine and growing pet healthcare awareness.

Vaccines
Vaccines make up about 15-20% of the market share. Increasing awareness about preventive care and rising vaccination rates among pets are propelling the demand for vaccines to protect animals from contagious diseases.

Companion Animal Healthcare Market, Segmentation by Diagnostic Tests

The Companion Animal Healthcare Market has been segmented by Diagnostic Tests into Diagnostic Imaging, Immunodiagnostic Tests, Molecular Diagnostics, Others and Retail pharmacies.

Diagnostic Imaging
Diagnostic imaging holds a significant share in the Companion Animal Healthcare Market, accounting for around 30-35%. This segment includes technologies such as X-rays, ultrasound, and MRI that enable veterinarians to accurately diagnose injuries and diseases in pets, improving treatment outcomes.

Immunodiagnostic Tests
Making up approximately 25-30% of the market, immunodiagnostic tests help detect immune responses in animals. These tests are essential for identifying infections, allergies, and autoimmune diseases, driving growth due to increased demand for precise diagnostics.

Molecular Diagnostics
Molecular diagnostics contribute around 15-20% to the market. This advanced segment uses techniques like PCR to detect genetic and infectious diseases at an early stage, facilitating timely intervention and better management of companion animal health.

Others
The ‘Others’ category, including various ancillary diagnostic services, accounts for roughly 10-15% of the market. This segment is growing as new technologies and testing methods continue to emerge in veterinary diagnostics.

Retail Pharmacies
Retail pharmacies represent about 5-10% of the market, providing convenient access to diagnostic test kits and related products for pet owners, which supports home-based care and early detection.

Companion Animal Healthcare Market, Segmentation by End Users

The Companion Animal Healthcare Market has been segmented by End Users into Veterinary Hospitals, Veterinary Clinics and Home Care.

Veterinary Hospitals
Veterinary hospitals dominate the Companion Animal Healthcare Market, accounting for approximately 45-50% of end-user share. These facilities offer advanced medical services and diagnostics, catering to complex animal health needs and specialized treatments.

Veterinary Clinics
Veterinary clinics hold around 35-40% of the market. They provide essential healthcare services, including routine check-ups and vaccinations, and are often the first point of contact for pet owners seeking medical attention for their animals.

Home Care
Home care is an emerging segment, representing about 10-15% of the market. This segment is growing due to increased pet owner preference for convenient, at-home health monitoring and care solutions, supported by the availability of home diagnostic kits and telemedicine services.

Companion Animal Healthcare Market, Segmentation by Geography

In this report, the Companion Animal Healthcare Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Companion Animal Healthcare Market Share (%), by Geographical Region.

North America
North America commands the largest share of the Companion Animal Healthcare Market, contributing nearly 40% of the global revenue. This dominance is fueled by high pet ownership, established veterinary infrastructure, and increased spending on pet insurance and preventive care.

Europe
Europe holds approximately 25–30% of the market, driven by growing awareness of animal health and a rise in pet adoption rates across countries such as Germany, France, and the United Kingdom. Supportive government regulations and investment in veterinary diagnostics further boost market growth.

Asia Pacific
Asia Pacific is emerging as the fastest-growing regional segment, with a market share of around 20%. This surge is attributed to rapid urbanization, increasing disposable income, and expanding awareness about companion animal wellness in nations like India, China, and Japan.

Middle East and Africa
The Middle East and Africa region accounts for about 5–8% of the global market. While still developing, the region is seeing increased investment in veterinary clinics and a growing focus on pet care in urban areas, particularly in South Africa and the Gulf countries.

Latin America
Latin America represents nearly 7–10% of the total market. Countries like Brazil, Mexico, and Argentina are witnessing steady growth due to rising pet ownership, expanding access to animal healthcare services, and greater awareness of preventive treatments.